AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

CUSIP: 03152W109

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
312,579,912
Total 13F shares
281,585,235
Share change
-652,487
Total reported value
$4,247,304,450
Put/Call ratio
11%
Price per share
$15.08
Number of holders
217
Value change
+$7,015,222
Number of buys
114
Number of sells
87

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
13F
Company
8.1%
25,182,364
$232,685,000 31 Mar 2020
13F
Redmile Group, LLC
13F
Company
8.1%
25,181,500
$232,677,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
7.7%
24,118,586
$222,856,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
6.8%
21,239,016
$196,248,000 31 Mar 2020
13F
MORGAN STANLEY
13F
Company
4%
12,374,950
$114,345,000 31 Mar 2020
13F
JANUS HENDERSON GROUP PLC
13F
Company
3.7%
11,625,924
$107,423,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
3.6%
11,129,151
$102,833,000 31 Mar 2020
13F
Avoro Capital Advisors LLC
13F
Company
3.5%
10,950,000
$101,178,000 31 Mar 2020
13F
FMR LLC
13F
Company
2.6%
8,067,808
$74,546,000 31 Mar 2020
13F
Palo Alto Investors LP
13F
Company
2.4%
7,447,618
$68,816,000 31 Mar 2020
13F
JPMORGAN CHASE & CO
13F
Company
2.1%
6,664,006
$61,575,000 31 Mar 2020
13F
D. E. Shaw & Co., Inc.
13F
Company
1.8%
5,565,739
$51,428,000 31 Mar 2020
13F
JENNISON ASSOCIATES LLC
13F
Company
1.6%
5,108,110
$47,199,000 31 Mar 2020
13F
Artal Group S.A.
13F
Company
1.6%
5,000,000
$46,200,000 31 Mar 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.5%
4,681,177
$43,254,000 31 Mar 2020
13F
DEUTSCHE BANK AG\
13F
Company
1.3%
4,121,242
$38,080,000 31 Mar 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
1.3%
4,005,484
$37,010,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
3,809,835
$35,202,000 31 Mar 2020
13F
Clearbridge Investments, LLC
13F
Company
1.2%
3,751,571
$34,665,000 31 Mar 2020
13F
NORGES BANK
13F
Company
1.2%
3,597,470
$33,241,000 31 Mar 2020
13F
NORTHERN TRUST CORP
13F
Company
1.1%
3,367,516
$31,115,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
3,331,187
$30,780,000 31 Mar 2020
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1%
3,253,960
$30,067,000 31 Mar 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.97%
3,033,160
$28,026,000 31 Mar 2020
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.91%
2,831,054
$26,158,000 31 Mar 2020
13F
Boxer Capital, LLC
13F
Company
0.74%
2,325,000
$21,483,000 31 Mar 2020
13F
Novo Holdings A/S
13F
Company
0.74%
2,320,026
$21,437,000 31 Mar 2020
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
0.72%
2,261,000
$20,892,000 31 Mar 2020
13F
Point72 Asset Management, L.P.
13F
Company
0.72%
2,242,900
$20,724,000 31 Mar 2020
13F
Bank of New York Mellon Corp
13F
Company
0.7%
2,196,853
$20,299,000 31 Mar 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.66%
2,075,428
$19,177,000 31 Mar 2020
13F
Hood River Capital Management LLC
13F
Company
0.65%
2,046,778
$18,912,000 31 Mar 2020
13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.
13F
Company
0.65%
2,033,120
$18,786,000 31 Mar 2020
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.65%
2,017,624
$18,643,000 31 Mar 2020
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.64%
1,991,652
$18,404,000 31 Mar 2020
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.6%
1,867,133
$17,252,000 31 Mar 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.59%
1,838,992
$16,993,000 31 Mar 2020
13F
CARILLON TOWER ADVISERS, INC.
13F
Company
0.59%
1,859,320
$16,473,575 31 Mar 2020
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.57%
1,779,191
$16,440,000 31 Mar 2020
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.5%
1,557,961
$14,396,000 31 Mar 2020
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.49%
1,544,819
$14,274,000 31 Mar 2020
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.45%
1,399,463
$12,931,000 31 Mar 2020
13F
Fairmount Funds Management LLC
13F
Company
0.43%
1,340,395
$12,385,000 31 Mar 2020
13F
Assenagon Asset Management S.A.
13F
Company
0.41%
1,282,055
$11,846,000 31 Mar 2020
13F
PEREGRINE CAPITAL MANAGEMENT LLC
13F
Company
0.4%
1,260,107
$11,643,000 31 Mar 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.4%
1,258,174
$11,626,000 31 Mar 2020
13F
Invesco Ltd.
13F
Company
0.4%
1,250,093
$11,551,000 31 Mar 2020
13F
EcoR1 Capital, LLC
13F
Company
0.4%
1,249,611
$11,546,000 31 Mar 2020
13F
Phoenix Financial Ltd.
13F
Company
0.38%
1,203,406
$10,861,000 31 Mar 2020
13F
Rock Springs Capital Management LP
13F
Company
0.32%
1,000,000
$9,240,000 31 Mar 2020
13F

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2020

As of 30 Jun 2020, AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by 217 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 281,585,235 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, STATE STREET CORP, MORGAN STANLEY, JPMORGAN CHASE & CO, and FMR LLC. This page lists 217 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
194
Q2 2020 holders
217
Holder diff
23
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.